Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRadimed Corporation stock logo
IRMD
iRadimed
$92.58
-0.6%
$92.91
$50.88
$107.90
$1.18B0.992,403 shs62,484 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$116.36
-1.3%
$118.98
$108.81
$212.00
$3.82B1.33615,056 shs240,209 shs
LivaNova PLC stock logo
LIVN
LivaNova
$73.96
+0.4%
$65.04
$41.01
$74.41
$4.06B0.82796,217 shs86,629 shs
Envista Holdings Corporation stock logo
NVST
Envista
$23.61
-0.1%
$25.64
$16.51
$30.42
$3.84B0.922.99 million shs615,958 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRadimed Corporation stock logo
IRMD
iRadimed
+3.06%+7.23%+4.47%-10.03%+75.10%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
+0.74%+3.25%-0.85%-21.92%-15.73%
LivaNova PLC stock logo
LIVN
LivaNova
-0.09%+2.75%+14.12%+7.63%+68.67%
Envista Holdings Corporation stock logo
NVST
Envista
-0.42%-0.82%-13.15%-18.71%+41.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRadimed Corporation stock logo
IRMD
iRadimed
$92.58
-0.6%
$92.91
$50.88
$107.90
$1.18B0.992,403 shs62,484 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$116.36
-1.3%
$118.98
$108.81
$212.00
$3.82B1.33615,056 shs240,209 shs
LivaNova PLC stock logo
LIVN
LivaNova
$73.96
+0.4%
$65.04
$41.01
$74.41
$4.06B0.82796,217 shs86,629 shs
Envista Holdings Corporation stock logo
NVST
Envista
$23.61
-0.1%
$25.64
$16.51
$30.42
$3.84B0.922.99 million shs615,958 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRadimed Corporation stock logo
IRMD
iRadimed
+3.06%+7.23%+4.47%-10.03%+75.10%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
+0.74%+3.25%-0.85%-21.92%-15.73%
LivaNova PLC stock logo
LIVN
LivaNova
-0.09%+2.75%+14.12%+7.63%+68.67%
Envista Holdings Corporation stock logo
NVST
Envista
-0.42%-0.82%-13.15%-18.71%+41.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iRadimed Corporation stock logo
IRMD
iRadimed
3.00
Buy$120.0029.62% Upside
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.93
Moderate Buy$191.8564.87% Upside
LivaNova PLC stock logo
LIVN
LivaNova
2.67
Moderate Buy$79.387.32% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.40
Hold$28.8322.15% Upside

Current Analyst Ratings Breakdown

Latest IRMD, LIVN, IRTC, and NVST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2026
iRadimed Corporation stock logo
IRMD
iRadimed
DowngradeBuy (B)Buy (B-)
5/18/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetBuy$225.00 ➝ $180.00
5/11/2026
Envista Holdings Corporation stock logo
NVST
Envista
DowngradeHold (C)Hold (C-)
5/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
UpgradeSell (D+)Hold (C)
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Reiterated RatingOutperform$33.00
5/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetEqual Weight$73.00 ➝ $76.00
5/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
Boost Price TargetOutperform$85.00 ➝ $90.00
5/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
Lower Price TargetOutperform$78.00 ➝ $76.00
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Boost Price TargetNeutral$26.00 ➝ $29.00
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Boost Price TargetOutperform$30.00 ➝ $31.00
5/6/2026
iRadimed Corporation stock logo
IRMD
iRadimed
UpgradeBuy (B-)Buy (B)
(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iRadimed Corporation stock logo
IRMD
iRadimed
$83.81M14.12$1.90 per share48.63$7.71 per share12.01
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$747.14M5.12N/AN/A$4.91 per share23.70
LivaNova PLC stock logo
LIVN
LivaNova
$1.39B2.93$4.85 per share15.24$22.05 per share3.35
Envista Holdings Corporation stock logo
NVST
Envista
$2.72B1.41$2.16 per share10.95$18.92 per share1.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iRadimed Corporation stock logo
IRMD
iRadimed
$22.48M$1.8350.35N/AN/A27.36%24.48%21.25%7/30/2026 (Estimated)
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.86N/A88.82N/A-3.53%-10.26%-1.39%7/30/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$1.9537.9218.13N/A7.48%16.48%7.59%8/5/2026 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
$47M$0.4157.5715.131.492.41%7.11%3.91%8/5/2026 (Estimated)

Latest IRMD, LIVN, IRTC, and NVST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2026Q1 2026
LivaNova PLC stock logo
LIVN
LivaNova
$0.85$0.98+$0.13$0.40$346.05 million$362.26 million
5/6/2026Q1 2026
Envista Holdings Corporation stock logo
NVST
Envista
$0.31$0.36+$0.05$0.23$680.04 millionN/A
5/1/2026Q1 2026
iRadimed Corporation stock logo
IRMD
iRadimed
$0.46$0.49+$0.03$0.45$21.32 million$21.98 million
4/30/2026Q1 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 million
2/25/2026Q4 2025
LivaNova PLC stock logo
LIVN
LivaNova
$0.80$0.86+$0.06$0.56$354.31 million$360.92 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
iRadimed Corporation stock logo
IRMD
iRadimed
$0.800.86%N/A43.72%1 Years
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A

Latest IRMD, LIVN, IRTC, and NVST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2026
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.200.93%5/15/20265/15/20265/29/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iRadimed Corporation stock logo
IRMD
iRadimed
N/A
7.13
6.15
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
4.03
5.17
4.98
LivaNova PLC stock logo
LIVN
LivaNova
0.24
1.33
1.11
Envista Holdings Corporation stock logo
NVST
Envista
0.47
2.44
2.06

Institutional Ownership

CompanyInstitutional Ownership
iRadimed Corporation stock logo
IRMD
iRadimed
92.34%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Envista Holdings Corporation stock logo
NVST
Envista
N/A

Insider Ownership

CompanyInsider Ownership
iRadimed Corporation stock logo
IRMD
iRadimed
36.80%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
Envista Holdings Corporation stock logo
NVST
Envista
0.99%
CompanyEmployeesShares OutstandingFree FloatOptionable
iRadimed Corporation stock logo
IRMD
iRadimed
11012.78 million8.08 millionOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.86 million32.54 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30054.93 million54.74 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,000162.73 million161.12 millionOptionable

Recent News About These Companies

Envista Q1 Earnings Call Highlights
Envista (NVST) Q1 2026 Earnings Transcript
Envista: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

iRadimed stock logo

iRadimed NASDAQ:IRMD

$92.58 -0.59 (-0.64%)
As of 12:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$116.36 -1.51 (-1.28%)
As of 12:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$73.96 +0.32 (+0.43%)
As of 01:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Envista stock logo

Envista NYSE:NVST

$23.60 -0.03 (-0.11%)
As of 01:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.